Frequency of Dyslipidemia in patients with Lupus Nephritis

被引:17
作者
Sajjad, Saba [1 ]
Farman, Sumaira [1 ]
Saeed, Muhammad Ahmed [1 ]
Ahmad, Nighat Mir [1 ]
Butt, Bilal Azeem [1 ]
机构
[1] Univ Hlth Sci, Fatima Mem Coll Med & Dent, Div Rheumatol, Lahore, Pakistan
关键词
Dyslipidemia; Lupus Nephritis; Systemic Lupus Erythematosus (SLE); ERYTHEMATOSUS; HYPERLIPIDEMIA; DISEASE; RISK;
D O I
10.12669/pjms.332.12410
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the frequency of dystipidemia in patients with lupus nephritis and its association with the degree of proteinuria. Methods: This cross-sectional analytic study included 65 patients who fulfilled the ACR (American College of Rheumatology) criteria for SLE and had renal involvement, presenting to the Division of Rheumatology, Fatima Memorial Hospital (FMH), and Lahore from 21st Sep 2016 to 20th Dec 2016. After 12 hours overnight fast their blood samples were assessed for total cholesterol (TC), triglycerides (TG), high density lipoprotein (HDL) and low density lipoprotein (LDL). Patient demographic variables (age, sex) and disease characteristics (disease duration, degree of proteinuria, steroid dose) were noted. Patients were categorized into two groups on the basis of degree of proteinuria: having proteinuria >1gm or <= 1gm. Data was analyzed using SPSS version 22. Individual lipid profiles were correlated with the degree of proteinuria. Results: Most common lipid abnormality found in our study was hypertriglyceridemia (58.5%). Total Cholesterol and LDL-C was high in 55.4% and 30.8% subjects respectively. Low HDL was found in 21.5% subjects. Increased frequency of dyslipidemia was noticed in those subjects who had proteinuria >1gm (P value < 0.05). Conclusion: Dyslipidemia was observed in a high frequency in patients with lupus nephritis and was strongly associated with their degree of proteinuria.
引用
收藏
页码:358 / 362
页数:5
相关论文
共 23 条
[1]   Dyslipidaemia in patients with lupus nephritis [J].
Chong, Yip Boon ;
Yap, Desmond Yh ;
Tang, Colin So ;
Chan, Tak Mao .
NEPHROLOGY, 2011, 16 (05) :511-517
[2]  
Era MD, 2013, SYSTEMIC LUPUS ERYTH, P187
[3]  
Junejo M, 2006, J SURG PAK, V11, P20
[4]  
Kakati S, 2003, J INDIAN RHEUMATOL A, V11, P5
[5]   Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus [J].
Reich, Heather N. ;
Gladman, Dafna D. ;
Urowitz, Murray B. ;
Bargman, Joanne M. ;
Hladunewich, Michelle A. ;
Lou, Wendy ;
Fan, Steve C. P. ;
Su, Jiandong ;
Herzenberg, Andrew M. ;
Cattran, Daniel C. ;
Wither, Joan ;
Landolt-Marticorena, Carol ;
Scholey, James W. ;
Fortin, Paul R. .
KIDNEY INTERNATIONAL, 2011, 79 (08) :914-920
[6]  
LEONG KH, 1994, J RHEUMATOL, V21, P1264
[7]  
Liu Li, 2014, Zhonghua Xin Xue Guan Bing Za Zhi, V42, P753
[8]   Oral Cyclophosphamide for Lupus Glomerulonephritis: An Underused Therapeutic Option [J].
McKinley, Alison ;
Park, Edward ;
Spetie, Dan ;
Hackshaw, Kevin V. ;
Nagaraja, Smitha ;
Hebert, Lee A. ;
Rovin, Brad H. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (11) :1754-1760
[9]   Atherosclerosis in systemic lupus erythematosus [J].
Mezalek, Zoubida Tazi ;
Harmouche, Hicham ;
Ammouri, Wafaa ;
Maamar, Mouna ;
Adnaoui, Mohamed ;
Cacoub, Patrice .
PRESSE MEDICALE, 2014, 43 (10) :1034-1047
[10]  
Muhammad N, 2004, JPMI, V18, P162